The generation of functional pancreatic β-cells from pluripotent stem cells (PSCs), including embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs), offers transformative opportunities in diabetes research and regenerative medicine, as primary human pancreatic β-cells are scarce and difficult to maintain in vitro. Stem cell-based differentiation has emerged as a scalable and renewable strategy to produce insulin-secreting β-like cells. This chapter provides an overview of the stepwise differentiation protocols that mimic human embryonic pancreatic β-cell development, highlighting the key signaling pathways and transcription factors involved at each stage. It also addresses critical challenges in achieving full β-cell maturation, including strategies such as 3D culture, co-culture systems, and environmental conditioning. Methods for isolating and enriching functional stem cell-derived β cells (SC-β), such as surface marker-based sorting, metabolic assays like glucose-stimulated insulin secretion (GSIS), and reaggregation into islet-like clusters, are discussed in detail. Functional validation techniques, including immunostaining, GSIS, and mitochondrial assessments, are emphasized to confirm SC-β cells identity and physiological function. Finally, this chapter highlights the use of SC-β cells in drug screening, disease modeling, and cell replacement therapies for diabetes. Continued advancements in differentiation protocols are positioning SC-β cells as vital resources for deepening our knowledge of diabetes and driving the development of effective cell replacement therapies.